CPTC-TERF2-2
Catalog Fields
Antigen: Telomeric repeat-binding factor 2
Hybridoma Cells Available: No
Antigen Species: Human
Depositor: Clinical Proteomics Technologies for Cancer
Isotype: MIgG1
Antigen Sequence:
Host Species: mouse
Depositors Institution: National Cancer Institute
Positive Tested Species Reactivity: Human
Depositors Notes: DNA Damage Response (DDR) Pathway / DNA-binding in cell cycle
Predicted Species Reactivity:
Gene: TERF2
Immunogen: Phosphorylated synthetic peptide
Alternate Gene Names: TRBF2, TRF2
Alternate Antibody Name:
Clonality: Monoclonal
Alternate Antigen Name:
Epitope Mapped: No
Myeloma Strain:
Epitope Location or Sequence:
Uniprot ID: Q15554
Immunogen Sequence: DLVLPTQALPA(pS)PALK
Entrez Gene ID: 7014
Additional Characterization: https://antibodies.cancer.gov/detail/CPTC-TERF2-2#CPTC-TERF2-2
Recommended Applications: ELISA
These hybridomas were created by your colleagues. Please acknowledge the hybridoma contributor and the Developmental Studies Hybridoma Bank (DSHB) in the Materials and Methods of your publications. Please email the citation to us.
For your Materials & Methods section:
CPTC-TERF2-2 was deposited to the DSHB by Clinical Proteomics Technologies for Cancer (DSHB Hybridoma Product CPTC-TERF2-2)
Storage and Handling Recommendations
Usage Recommendations
All cell products contain the antimicrobial ProClin. Click here for additional information.
1 Reference
Initial Publication
A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage.
Paulovich AG
Radiation research 189.5 (2018 May): 505-518.